Literature DB >> 15085360

[Acute coronary syndrome (without ST-elevation)].

H-J Rupprecht1, S Genth-Zotz, W Jungmair, C Espinola-Klein, S Blankenberg, F Post.   

Abstract

Antithrombotic therapy in acute coronary syndrome without ST-segment elevation should be initiated with aspirin 100 mg/day (loading dose 250-500 mg) and Clopidogrel 75 mg/day (loading dose 300 mg). In addition, anticoagulation with unfractionated heparin or low molecular weight heparin should be started. A GP IIb/IIIa receptor blocker can be given either upfront (Eptifibatide/Tirofiban) or directly in the cathlab preceding PCI (Abciximab). Aspirin should be given in the chronic phase lifelong, Clopidogrel for at least nine months. An invasive strategy is recommended in high-risk patients within 48 hours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085360     DOI: 10.1007/s00392-004-1401-5

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  2 in total

1.  A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.

Authors:  Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Kathrin Niemöller; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2006-10-30       Impact factor: 5.460

2.  Splenic rupture complicating periinterventional glycoprotein IIb/IIIa antagonist therapy for myocardial infarction in polycythemia vera.

Authors:  E B Friedrich; M Kindermann; A Link; M Böhm
Journal:  Z Kardiol       Date:  2005-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.